A partnership with Anglo Scientific, who are experts at selecting, building and exiting from technology businesses, having invested using this strategy for over 10 years.
This EIS invests in companies that are using technology to help solve global issues predominantly in 3 sub-sectors: security; healthcare; and communications.
The companies will all have defensible IP, a truly global market, and be able to demonstrate a clear route to over £100m annually in revenues.
A known portfolio of companies at time of investment
Quick deployment of capital (circa 3 months)
Managed by a combined team of experts – Amberside Capital and Anglo Scientific
ALL investee companies personally invested in by the Directors of Amberside Capital/Anglo Scientific on the same terms as EIS investors
We will be targeting exits in 5-7 years from the date of investment, although it could take longer than
this. These exits will likely be provided by one of the following: a trade sale, management buyout, or
Date of exit
Value on exit
(net of reliefs)
2017 - 2021
as exit phased
3.00x – 5.00x
also held in
escrow for 18
months post sale
amount left in
3.50x – 13.80x
Amberside Capital aim to bring the highest standards of institutional management rigour to the retail investment market. This investment rigour covers all activities from the comprehensive due diligence undertaken in making investments, the detailed risk management which governs our management of investments, and the transparency we bring to investor reporting and the investment process.
Anglo Scientific are a team of entrepreneurs who set out to build high potential technology-driven companies. They aim to identify ground breaking science that can solve globally challenging problems in predominantly 3 key sub-sectors: healthcare; communications; security.
They currently have a portfolio of 9 such companies, that are collectively valued at over £200 million, from a total of £88.5m invested.
20% on portfolio level returns
Kuber Special Arrangements
For further information please do not hesitate to contact us on: